Skip to content
Search

Latest Stories

Combating wage theft: PDA assists locum pharmacists in reclaiming £65,000 in 2023

The Pharmacists' Defence Association stated that pharmacists and trainee pharmacists often fall victim to wage theft by employers and contractors, which involves unpaid overtime, wage deductions, and withheld payments. In 2023, the PDA aided locum pharmacists in reclaiming a sum of £65,000 in unpaid wages.

In a recent instance, the union aided a locum in recovering £8,000 owed by an employer, highlighting its ongoing commitment to assisting locums in obtaining rightful compensation for their work shifts.


According to the PDA, wage theft involves the retention of rightful wages or entitled employee benefits, including underpayment of contractual pay, omission of hours worked, or incomplete holiday compensation. This term also applies when a pharmacy contractor holds back payment for services rendered by a locum.

The PDA underscored the significance of pharmacists retaining a personal copy of their respective agreements, while highlighting the diversity of employment and locum contracts. "Contracts should define pay rates and the conditions for earning such payment. If additional work is requested by the employer, compensation should align with the contract terms or result from a separate agreement surpassing the initial terms,” the union added.

This year, the PDA initiated claims for unlawful wage deductions against a range of employers, including the NHS, major and minor pharmacy chains, and certain independent contractors.

Trainees most vulnerable to wage theft

Trainee pharmacists are frequently obligated to perform unpaid overtime, the PDA said. Typically regarded as supernumerary, trainees receive grants to cover their training expenses. If a trainee chooses to work extra hours, the PDA emphasised they should be compensated with overtime pay in accordance with their contract."

The PDA noted another situation they have come across where trainees discover upon arriving at their placement that their employer intends to make deductions from their wages. “Trainees, often young individuals starting their careers and embarking on their first full-time job, can find themselves in a vulnerable position,” the association said.

The PDA also noted that they might feel less assured when asserting their employment rights because their designated supervisor plays a dual role as both their evaluator for successful training completion and their potential manager or employer.

"It is simply unacceptable that pharmacists are forced to battle for the retrieval of money rightfully owed to them by employers and pharmacy contractors, especially during a period marked by a cost-of-living crisis," said Mark Pitt, PDA Director of Defence Services and PDA Union General Secretary. "Despite potential financial pressures on some pharmacies, employers remain bound by firm legal and contractual commitments to pharmacists, which must be upheld."

The PDA recently expressed concerns about the General Pharmaceutical Council's plan to raise registration fees for pharmacists, pharmacy technicians, and pharmacy premises. They criticised the GPhC's justification for the fee increase as insufficient. The union highlighted a notable level of concern indicated in its member survey responses, particularly relating to the GPhC premises in Canary Wharf.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less